DDAH1 deficiency promotes intracellular oxidative stress and cell apoptosis via a miR-21-dependent pathway in mouse embryonic fibroblasts

Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, is degraded by dimethylarginine dimethylaminohydrolase 1 (DDAH1). Emerging evidence suggests that plasma ADMA accumulation, DDAH1 activity/expression reduction, and microRNA-21 (miR-21) upregulation are linked t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Free radical biology & medicine 2016-03, Vol.92, p.50-60
Hauptverfasser: Zhao, Chenyang, Li, Tianhe, Han, Bingxing, Yue, Wenhui, Shi, Linlin, Wang, Hongyun, Guo, Yuting, Lu, Zhongbing
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 60
container_issue
container_start_page 50
container_title Free radical biology & medicine
container_volume 92
creator Zhao, Chenyang
Li, Tianhe
Han, Bingxing
Yue, Wenhui
Shi, Linlin
Wang, Hongyun
Guo, Yuting
Lu, Zhongbing
description Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, is degraded by dimethylarginine dimethylaminohydrolase 1 (DDAH1). Emerging evidence suggests that plasma ADMA accumulation, DDAH1 activity/expression reduction, and microRNA-21 (miR-21) upregulation are linked to disease pathology, but the mechanisms remain largely unknown. In the present study, we assessed the potential role of the ADMA–DDAH1–miR-21 pathway in the regulation of the cellular redox state and apoptosis using wild-type (WT) and DDAH1-knockout (KO) immortalized mouse embryonic fibroblasts (MEFs). DDAH1 deficiency significantly increased ADMA levels, enhanced cellular oxidative stress, and rendered cells more vulnerable to apoptosis induced by tert-butyl hydroperoxide (tBHP) or A23187. However, treatment with exogenous ADMA (1–80μM) for 24h or for a prolonged period (10μM, 10 passages) in WT MEFs had no marked effect on intracellular reactive oxygen species (ROS) and apoptosis sensitivity. Interestingly, miR-21 expression was significantly increased, by 4 fold, in DDAH1−/− MEFs, and the induction of miR-21 by DDAH1 deficiency was dependent on oxidative stress and NF-κB activation. Inhibition of DDAH1 activity by PD 404182 also increased miR-21 expression. Furthermore, inhibition of miR-21 with a lentiviral vector in DDAH1−/− MEFs significantly upregulated SOD2 expression and the attenuated oxidative stress and apoptosis induced by tBHP or A23187. Taken together, our results suggest that DDAH1 not only acts as an enzyme degrading ADMA but also controls cellular oxidative stress and apoptosis via a miR-21-dependent pathway. [Display omitted] •DDAH1 deficiency exacerbates tBHP- and A23187-induced viability loss and apoptosis.•DDAH1 deficiency increases oxidative stress through downregulation of SOD2.•MiR-21 was upregulated in Ddah1−/− MEFs.•NF-κB activation contributes to miR-21 expression in Ddah1−/− MEFs.•Inhibition of miR-21 ameliorates apoptosis and oxidative stress in Ddah1−/− MEFs.
doi_str_mv 10.1016/j.freeradbiomed.2016.01.015
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1768554433</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0891584916000290</els_id><sourcerecordid>1768554433</sourcerecordid><originalsourceid>FETCH-LOGICAL-c453t-39d476635bb7f1a0d60c0313af7838a579449ffcd4d07d4c21f4ac374f59d00b3</originalsourceid><addsrcrecordid>eNqNUU1rHDEMNaEh2ab9C8XQSy-zsdf2fNBTSNKmEAiE9mw0tky9zIyntnfb_Qn91_F0k0NvAYFAetLT0yPkI2drznh9uV27iBjB9j6MaNebUlwzXkKdkBVvG1FJ1dVvyIq1Ha9UK7tz8jalLWNMKtGekfNN3bJaKb4if29uru44tei88TiZA51jGEPGRP2UIxgcht0AkYY_3kL2e6QpR0yJwmTp0qUwhzmH5BPde6BAR_9YbXhlccbJ4pTpDPnnbziUhXQMu4QUxz4ewuQNdb6PoR8g5fSOnDoYEr5_zhfkx5fb79d31f3D12_XV_eVKcfnSnRWNnUtVN83jgOzNTNMcAGuaUULqumk7JwzVlrWWGk23EkwopFOdZaxXlyQT8e9ReivHaasR58WITBhuU7zpm6VklKIAv18hJoYUoro9Bz9CPGgOdOLF3qr__NCL15oxkuoMv3hmWjXL72X2ZfnF8DtEYBF7t5j1OmfB2h9RJO1Df5VRE9x8aTI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1768554433</pqid></control><display><type>article</type><title>DDAH1 deficiency promotes intracellular oxidative stress and cell apoptosis via a miR-21-dependent pathway in mouse embryonic fibroblasts</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Zhao, Chenyang ; Li, Tianhe ; Han, Bingxing ; Yue, Wenhui ; Shi, Linlin ; Wang, Hongyun ; Guo, Yuting ; Lu, Zhongbing</creator><creatorcontrib>Zhao, Chenyang ; Li, Tianhe ; Han, Bingxing ; Yue, Wenhui ; Shi, Linlin ; Wang, Hongyun ; Guo, Yuting ; Lu, Zhongbing</creatorcontrib><description>Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, is degraded by dimethylarginine dimethylaminohydrolase 1 (DDAH1). Emerging evidence suggests that plasma ADMA accumulation, DDAH1 activity/expression reduction, and microRNA-21 (miR-21) upregulation are linked to disease pathology, but the mechanisms remain largely unknown. In the present study, we assessed the potential role of the ADMA–DDAH1–miR-21 pathway in the regulation of the cellular redox state and apoptosis using wild-type (WT) and DDAH1-knockout (KO) immortalized mouse embryonic fibroblasts (MEFs). DDAH1 deficiency significantly increased ADMA levels, enhanced cellular oxidative stress, and rendered cells more vulnerable to apoptosis induced by tert-butyl hydroperoxide (tBHP) or A23187. However, treatment with exogenous ADMA (1–80μM) for 24h or for a prolonged period (10μM, 10 passages) in WT MEFs had no marked effect on intracellular reactive oxygen species (ROS) and apoptosis sensitivity. Interestingly, miR-21 expression was significantly increased, by 4 fold, in DDAH1−/− MEFs, and the induction of miR-21 by DDAH1 deficiency was dependent on oxidative stress and NF-κB activation. Inhibition of DDAH1 activity by PD 404182 also increased miR-21 expression. Furthermore, inhibition of miR-21 with a lentiviral vector in DDAH1−/− MEFs significantly upregulated SOD2 expression and the attenuated oxidative stress and apoptosis induced by tBHP or A23187. Taken together, our results suggest that DDAH1 not only acts as an enzyme degrading ADMA but also controls cellular oxidative stress and apoptosis via a miR-21-dependent pathway. [Display omitted] •DDAH1 deficiency exacerbates tBHP- and A23187-induced viability loss and apoptosis.•DDAH1 deficiency increases oxidative stress through downregulation of SOD2.•MiR-21 was upregulated in Ddah1−/− MEFs.•NF-κB activation contributes to miR-21 expression in Ddah1−/− MEFs.•Inhibition of miR-21 ameliorates apoptosis and oxidative stress in Ddah1−/− MEFs.</description><identifier>ISSN: 0891-5849</identifier><identifier>EISSN: 1873-4596</identifier><identifier>DOI: 10.1016/j.freeradbiomed.2016.01.015</identifier><identifier>PMID: 26806551</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>ADMA ; Amidohydrolases - antagonists &amp; inhibitors ; Amidohydrolases - genetics ; Amidohydrolases - metabolism ; Animals ; Apoptosis - drug effects ; Arginine - administration &amp; dosage ; Arginine - analogs &amp; derivatives ; DDAH1 ; Embryo, Mammalian - drug effects ; Embryo, Mammalian - metabolism ; Endothelial Cells - drug effects ; Endothelial Cells - metabolism ; Enzyme Inhibitors - administration &amp; dosage ; Fibroblasts - drug effects ; Fibroblasts - metabolism ; Gene Expression Regulation - drug effects ; Mice ; MicroRNAs - genetics ; MicroRNAs - metabolism ; miRNA ; NF-kappa B - genetics ; Nitric Oxide - genetics ; Nitric Oxide Synthase Type III - antagonists &amp; inhibitors ; Nitric Oxide Synthase Type III - genetics ; Oxidative stress ; Oxidative Stress - genetics ; Signal Transduction - drug effects ; SOD2 ; Superoxide Dismutase - biosynthesis</subject><ispartof>Free radical biology &amp; medicine, 2016-03, Vol.92, p.50-60</ispartof><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c453t-39d476635bb7f1a0d60c0313af7838a579449ffcd4d07d4c21f4ac374f59d00b3</citedby><cites>FETCH-LOGICAL-c453t-39d476635bb7f1a0d60c0313af7838a579449ffcd4d07d4c21f4ac374f59d00b3</cites><orcidid>0000-0002-2717-4698</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0891584916000290$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26806551$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhao, Chenyang</creatorcontrib><creatorcontrib>Li, Tianhe</creatorcontrib><creatorcontrib>Han, Bingxing</creatorcontrib><creatorcontrib>Yue, Wenhui</creatorcontrib><creatorcontrib>Shi, Linlin</creatorcontrib><creatorcontrib>Wang, Hongyun</creatorcontrib><creatorcontrib>Guo, Yuting</creatorcontrib><creatorcontrib>Lu, Zhongbing</creatorcontrib><title>DDAH1 deficiency promotes intracellular oxidative stress and cell apoptosis via a miR-21-dependent pathway in mouse embryonic fibroblasts</title><title>Free radical biology &amp; medicine</title><addtitle>Free Radic Biol Med</addtitle><description>Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, is degraded by dimethylarginine dimethylaminohydrolase 1 (DDAH1). Emerging evidence suggests that plasma ADMA accumulation, DDAH1 activity/expression reduction, and microRNA-21 (miR-21) upregulation are linked to disease pathology, but the mechanisms remain largely unknown. In the present study, we assessed the potential role of the ADMA–DDAH1–miR-21 pathway in the regulation of the cellular redox state and apoptosis using wild-type (WT) and DDAH1-knockout (KO) immortalized mouse embryonic fibroblasts (MEFs). DDAH1 deficiency significantly increased ADMA levels, enhanced cellular oxidative stress, and rendered cells more vulnerable to apoptosis induced by tert-butyl hydroperoxide (tBHP) or A23187. However, treatment with exogenous ADMA (1–80μM) for 24h or for a prolonged period (10μM, 10 passages) in WT MEFs had no marked effect on intracellular reactive oxygen species (ROS) and apoptosis sensitivity. Interestingly, miR-21 expression was significantly increased, by 4 fold, in DDAH1−/− MEFs, and the induction of miR-21 by DDAH1 deficiency was dependent on oxidative stress and NF-κB activation. Inhibition of DDAH1 activity by PD 404182 also increased miR-21 expression. Furthermore, inhibition of miR-21 with a lentiviral vector in DDAH1−/− MEFs significantly upregulated SOD2 expression and the attenuated oxidative stress and apoptosis induced by tBHP or A23187. Taken together, our results suggest that DDAH1 not only acts as an enzyme degrading ADMA but also controls cellular oxidative stress and apoptosis via a miR-21-dependent pathway. [Display omitted] •DDAH1 deficiency exacerbates tBHP- and A23187-induced viability loss and apoptosis.•DDAH1 deficiency increases oxidative stress through downregulation of SOD2.•MiR-21 was upregulated in Ddah1−/− MEFs.•NF-κB activation contributes to miR-21 expression in Ddah1−/− MEFs.•Inhibition of miR-21 ameliorates apoptosis and oxidative stress in Ddah1−/− MEFs.</description><subject>ADMA</subject><subject>Amidohydrolases - antagonists &amp; inhibitors</subject><subject>Amidohydrolases - genetics</subject><subject>Amidohydrolases - metabolism</subject><subject>Animals</subject><subject>Apoptosis - drug effects</subject><subject>Arginine - administration &amp; dosage</subject><subject>Arginine - analogs &amp; derivatives</subject><subject>DDAH1</subject><subject>Embryo, Mammalian - drug effects</subject><subject>Embryo, Mammalian - metabolism</subject><subject>Endothelial Cells - drug effects</subject><subject>Endothelial Cells - metabolism</subject><subject>Enzyme Inhibitors - administration &amp; dosage</subject><subject>Fibroblasts - drug effects</subject><subject>Fibroblasts - metabolism</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Mice</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - metabolism</subject><subject>miRNA</subject><subject>NF-kappa B - genetics</subject><subject>Nitric Oxide - genetics</subject><subject>Nitric Oxide Synthase Type III - antagonists &amp; inhibitors</subject><subject>Nitric Oxide Synthase Type III - genetics</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - genetics</subject><subject>Signal Transduction - drug effects</subject><subject>SOD2</subject><subject>Superoxide Dismutase - biosynthesis</subject><issn>0891-5849</issn><issn>1873-4596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUU1rHDEMNaEh2ab9C8XQSy-zsdf2fNBTSNKmEAiE9mw0tky9zIyntnfb_Qn91_F0k0NvAYFAetLT0yPkI2drznh9uV27iBjB9j6MaNebUlwzXkKdkBVvG1FJ1dVvyIq1Ha9UK7tz8jalLWNMKtGekfNN3bJaKb4if29uru44tei88TiZA51jGEPGRP2UIxgcht0AkYY_3kL2e6QpR0yJwmTp0qUwhzmH5BPde6BAR_9YbXhlccbJ4pTpDPnnbziUhXQMu4QUxz4ewuQNdb6PoR8g5fSOnDoYEr5_zhfkx5fb79d31f3D12_XV_eVKcfnSnRWNnUtVN83jgOzNTNMcAGuaUULqumk7JwzVlrWWGk23EkwopFOdZaxXlyQT8e9ReivHaasR58WITBhuU7zpm6VklKIAv18hJoYUoro9Bz9CPGgOdOLF3qr__NCL15oxkuoMv3hmWjXL72X2ZfnF8DtEYBF7t5j1OmfB2h9RJO1Df5VRE9x8aTI</recordid><startdate>201603</startdate><enddate>201603</enddate><creator>Zhao, Chenyang</creator><creator>Li, Tianhe</creator><creator>Han, Bingxing</creator><creator>Yue, Wenhui</creator><creator>Shi, Linlin</creator><creator>Wang, Hongyun</creator><creator>Guo, Yuting</creator><creator>Lu, Zhongbing</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2717-4698</orcidid></search><sort><creationdate>201603</creationdate><title>DDAH1 deficiency promotes intracellular oxidative stress and cell apoptosis via a miR-21-dependent pathway in mouse embryonic fibroblasts</title><author>Zhao, Chenyang ; Li, Tianhe ; Han, Bingxing ; Yue, Wenhui ; Shi, Linlin ; Wang, Hongyun ; Guo, Yuting ; Lu, Zhongbing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c453t-39d476635bb7f1a0d60c0313af7838a579449ffcd4d07d4c21f4ac374f59d00b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>ADMA</topic><topic>Amidohydrolases - antagonists &amp; inhibitors</topic><topic>Amidohydrolases - genetics</topic><topic>Amidohydrolases - metabolism</topic><topic>Animals</topic><topic>Apoptosis - drug effects</topic><topic>Arginine - administration &amp; dosage</topic><topic>Arginine - analogs &amp; derivatives</topic><topic>DDAH1</topic><topic>Embryo, Mammalian - drug effects</topic><topic>Embryo, Mammalian - metabolism</topic><topic>Endothelial Cells - drug effects</topic><topic>Endothelial Cells - metabolism</topic><topic>Enzyme Inhibitors - administration &amp; dosage</topic><topic>Fibroblasts - drug effects</topic><topic>Fibroblasts - metabolism</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Mice</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - metabolism</topic><topic>miRNA</topic><topic>NF-kappa B - genetics</topic><topic>Nitric Oxide - genetics</topic><topic>Nitric Oxide Synthase Type III - antagonists &amp; inhibitors</topic><topic>Nitric Oxide Synthase Type III - genetics</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - genetics</topic><topic>Signal Transduction - drug effects</topic><topic>SOD2</topic><topic>Superoxide Dismutase - biosynthesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhao, Chenyang</creatorcontrib><creatorcontrib>Li, Tianhe</creatorcontrib><creatorcontrib>Han, Bingxing</creatorcontrib><creatorcontrib>Yue, Wenhui</creatorcontrib><creatorcontrib>Shi, Linlin</creatorcontrib><creatorcontrib>Wang, Hongyun</creatorcontrib><creatorcontrib>Guo, Yuting</creatorcontrib><creatorcontrib>Lu, Zhongbing</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Free radical biology &amp; medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhao, Chenyang</au><au>Li, Tianhe</au><au>Han, Bingxing</au><au>Yue, Wenhui</au><au>Shi, Linlin</au><au>Wang, Hongyun</au><au>Guo, Yuting</au><au>Lu, Zhongbing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DDAH1 deficiency promotes intracellular oxidative stress and cell apoptosis via a miR-21-dependent pathway in mouse embryonic fibroblasts</atitle><jtitle>Free radical biology &amp; medicine</jtitle><addtitle>Free Radic Biol Med</addtitle><date>2016-03</date><risdate>2016</risdate><volume>92</volume><spage>50</spage><epage>60</epage><pages>50-60</pages><issn>0891-5849</issn><eissn>1873-4596</eissn><abstract>Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, is degraded by dimethylarginine dimethylaminohydrolase 1 (DDAH1). Emerging evidence suggests that plasma ADMA accumulation, DDAH1 activity/expression reduction, and microRNA-21 (miR-21) upregulation are linked to disease pathology, but the mechanisms remain largely unknown. In the present study, we assessed the potential role of the ADMA–DDAH1–miR-21 pathway in the regulation of the cellular redox state and apoptosis using wild-type (WT) and DDAH1-knockout (KO) immortalized mouse embryonic fibroblasts (MEFs). DDAH1 deficiency significantly increased ADMA levels, enhanced cellular oxidative stress, and rendered cells more vulnerable to apoptosis induced by tert-butyl hydroperoxide (tBHP) or A23187. However, treatment with exogenous ADMA (1–80μM) for 24h or for a prolonged period (10μM, 10 passages) in WT MEFs had no marked effect on intracellular reactive oxygen species (ROS) and apoptosis sensitivity. Interestingly, miR-21 expression was significantly increased, by 4 fold, in DDAH1−/− MEFs, and the induction of miR-21 by DDAH1 deficiency was dependent on oxidative stress and NF-κB activation. Inhibition of DDAH1 activity by PD 404182 also increased miR-21 expression. Furthermore, inhibition of miR-21 with a lentiviral vector in DDAH1−/− MEFs significantly upregulated SOD2 expression and the attenuated oxidative stress and apoptosis induced by tBHP or A23187. Taken together, our results suggest that DDAH1 not only acts as an enzyme degrading ADMA but also controls cellular oxidative stress and apoptosis via a miR-21-dependent pathway. [Display omitted] •DDAH1 deficiency exacerbates tBHP- and A23187-induced viability loss and apoptosis.•DDAH1 deficiency increases oxidative stress through downregulation of SOD2.•MiR-21 was upregulated in Ddah1−/− MEFs.•NF-κB activation contributes to miR-21 expression in Ddah1−/− MEFs.•Inhibition of miR-21 ameliorates apoptosis and oxidative stress in Ddah1−/− MEFs.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26806551</pmid><doi>10.1016/j.freeradbiomed.2016.01.015</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-2717-4698</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0891-5849
ispartof Free radical biology & medicine, 2016-03, Vol.92, p.50-60
issn 0891-5849
1873-4596
language eng
recordid cdi_proquest_miscellaneous_1768554433
source MEDLINE; Elsevier ScienceDirect Journals
subjects ADMA
Amidohydrolases - antagonists & inhibitors
Amidohydrolases - genetics
Amidohydrolases - metabolism
Animals
Apoptosis - drug effects
Arginine - administration & dosage
Arginine - analogs & derivatives
DDAH1
Embryo, Mammalian - drug effects
Embryo, Mammalian - metabolism
Endothelial Cells - drug effects
Endothelial Cells - metabolism
Enzyme Inhibitors - administration & dosage
Fibroblasts - drug effects
Fibroblasts - metabolism
Gene Expression Regulation - drug effects
Mice
MicroRNAs - genetics
MicroRNAs - metabolism
miRNA
NF-kappa B - genetics
Nitric Oxide - genetics
Nitric Oxide Synthase Type III - antagonists & inhibitors
Nitric Oxide Synthase Type III - genetics
Oxidative stress
Oxidative Stress - genetics
Signal Transduction - drug effects
SOD2
Superoxide Dismutase - biosynthesis
title DDAH1 deficiency promotes intracellular oxidative stress and cell apoptosis via a miR-21-dependent pathway in mouse embryonic fibroblasts
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T16%3A38%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DDAH1%20deficiency%20promotes%20intracellular%20oxidative%20stress%20and%20cell%20apoptosis%20via%20a%20miR-21-dependent%20pathway%20in%20mouse%20embryonic%20fibroblasts&rft.jtitle=Free%20radical%20biology%20&%20medicine&rft.au=Zhao,%20Chenyang&rft.date=2016-03&rft.volume=92&rft.spage=50&rft.epage=60&rft.pages=50-60&rft.issn=0891-5849&rft.eissn=1873-4596&rft_id=info:doi/10.1016/j.freeradbiomed.2016.01.015&rft_dat=%3Cproquest_cross%3E1768554433%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1768554433&rft_id=info:pmid/26806551&rft_els_id=S0891584916000290&rfr_iscdi=true